Actinium Pharmaceuticals Inc Stock Price (ATNM)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $650.00Sat, 1 Apr 2023 06:02:54 UTC via ETF Daily News
Stratos Wealth Advisors LLC Buys New Position in iShares U.S. Healthcare ETF (NYSEARCA:IYH)Sat, 1 Apr 2023 05:58:46 UTC via ETF Daily News
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 3,225 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sat, 1 Apr 2023 05:41:03 UTC via ETF Daily News
Insider Selling: AMN Healthcare Services, Inc. (NYSE:AMN) Insider Sells 4,515 Shares of StockSat, 1 Apr 2023 05:28:49 UTC via ETF Daily News
Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50 Day Moving Average of $3.59Sat, 1 Apr 2023 05:26:42 UTC via ETF Daily News
FY2026 EPS Estimates for Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Raised by HC WainwrightSat, 1 Apr 2023 03:52:41 UTC via ETF Daily News
ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Pass Above 200 Day Moving Average of $17.29Sat, 1 Apr 2023 03:42:45 UTC via ETF Daily News
Fusion Pharmaceuticals (NASDAQ:FUSN) Stock Rating Reaffirmed by B. RileySat, 1 Apr 2023 03:00:41 UTC via ETF Daily News
Satsuma Pharmaceuticals (NASDAQ:STSA) Given “Neutral” Rating at MizuhoSat, 1 Apr 2023 02:54:43 UTC via ETF Daily News
Financial Contrast: AlerisLife (NASDAQ:ALR) versus National HealthCare (NYSE:NHC)Sat, 1 Apr 2023 02:50:41 UTC via ETF Daily News

Actinium Pharmaceuticals Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ATNM

You don't have any alerts set for IEX:ATNM.

About Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.

CEOSandesh Seth IndustryBiotechnology SectorHealthcare Websitehttps://www.actiniumpharma.com Issue ExchangeNYSE American Issue TypeUnknown

Real-time ATNM to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.